Free Trial

Ocular Therapeutix (OCUL) Earnings Date, Estimates & Call Transcripts

Ocular Therapeutix logo
$10.39
-0.14 (-1.33%)
(As of 11/1/2024 ET)

Ocular Therapeutix Latest Earnings Summary

Upcoming Q3
Earnings Date
Nov. 5Estimated
Actual EPS
(Aug. 7)
-$0.26 Missed By -$0.04
Consensus EPS
(Aug. 7)
-$0.22

Ocular Therapeutix announced Q2 2024 earnings on August 7, 2024, reporting an EPS of -$0.26, which missed analysts' consensus estimates of -$0.22 by $0.04. Quarterly revenue rose 7.9% year-over-year to $16.40 million, above the consensus estimate of $15.85 million. With a trailing EPS of -$1.35, Ocular Therapeutix's earnings are expected to grow next year, from ($1.02) to ($0.97) per share.

OCUL Upcoming Earnings

Ocular Therapeutix's next earnings date is estimated for Tuesday, November 5, 2024, based off prior year's reporting schedules.

Get Ocular Therapeutix Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Ocular Therapeutix and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

OCUL Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

OCUL Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Ocular Therapeutix Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241-$0.16-$0.16-$0.16
Q2 20241-$0.14-$0.14-$0.14
Q3 20241-$0.13-$0.13-$0.13
Q4 20241-$0.13-$0.13-$0.13
FY 20244-$0.56-$0.56-$0.56
Q1 20251-$0.14-$0.14-$0.14
Q2 20251-$0.14-$0.14-$0.14
Q3 20251-$0.14-$0.14-$0.14
Q4 20251-$0.13-$0.13-$0.13
FY 20254($0.55)($0.55)($0.55)

Ocular Therapeutix Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
11/5/2024
(Estimated)
------- 
8/7/2024Q2 2024-$0.22-$0.26 -$0.04-$0.22$15.85M$16.40M      
5/7/2024Q1 2024-$0.18-$0.24 -$0.06$0.01$15.43M$14.77M  
3/11/2024Q4 2023-$0.28-$0.28--$0.21$15.31M$14.80M  
11/7/2023Q3 2023-$0.27-$0.51 -$0.24-$0.77$15.41M$15.08M  
8/7/2023Q2 2023-$0.29-$0.27+$0.02-$0.28$14.64M$15.19M  
5/8/2023Q1 2023-$0.27-$0.31 -$0.04-$0.23$14.02M$13.37M  
3/6/2023Q4 2022-$0.25-$0.24+$0.01-$0.24$13.60M$14.08M  
11/7/2022Q3 2022-$0.23-$0.30 -$0.07-$0.29$14.71M$11.97M  

Ocular Therapeutix Earnings - Frequently Asked Questions

Ocular Therapeutix has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 5th, 2024 based off last year's report dates. Learn more on OCUL's earnings history.

In the previous quarter, Ocular Therapeutix (NASDAQ:OCUL) missed the analysts' consensus estimate of ($0.22) by $0.04 with a reported earnings per share (EPS) of ($0.26). Learn more on analysts' earnings estimate vs. OCUL's actual earnings.

The conference call for Ocular Therapeutix's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Ocular Therapeutix's latest earnings report can be read online.
Read Transcript

Ocular Therapeutix (NASDAQ:OCUL) has a recorded annual revenue of $61.10 million.

Ocular Therapeutix (NASDAQ:OCUL) has a recorded net income of -$80.74 million. OCUL has generated -$1.35 earnings per share over the last four quarters.

Ocular Therapeutix's earnings are expected to grow from ($1.02) per share to ($0.97) per share in the next year.

`

More Earnings Resources from MarketBeat



This page (NASDAQ:OCUL) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners